ID   PUS10_HUMAN             Reviewed;         529 AA.
AC   Q3MIT2; Q5JPJ5; Q96MI8;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2005, sequence version 1.
DT   07-APR-2021, entry version 121.
DE   RecName: Full=tRNA pseudouridine synthase Pus10;
DE            Short=Hup10 {ECO:0000303|PubMed:28981101};
DE            EC=5.4.99.25 {ECO:0000269|PubMed:31819270};
DE   AltName: Full=Coiled-coil domain-containing protein 139 {ECO:0000312|HGNC:HGNC:26505};
DE   AltName: Full=tRNA pseudouridine 55 synthase;
DE            Short=Psi55 synthase;
DE   AltName: Full=tRNA pseudouridylate synthase;
DE   AltName: Full=tRNA-uridine isomerase;
GN   Name=PUS10 {ECO:0000312|HGNC:HGNC:26505};
GN   Synonyms=CCDC139 {ECO:0000312|HGNC:HGNC:26505},
GN   DOBI {ECO:0000303|PubMed:19712588};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=14527409; DOI=10.1016/s1097-2765(03)00348-4;
RA   Aza-Blanc P., Cooper C.L., Wagner K., Batalov S., Deveraux Q.L.,
RA   Cooke M.P.;
RT   "Identification of modulators of TRAIL-induced apoptosis via RNAi-based
RT   phenotypic screening.";
RL   Mol. Cell 12:627-637(2003).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79 AND SER-84, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [7]
RP   PROTEOLYTIC CLEAVAGE, AND FUNCTION.
RX   PubMed=19712588; DOI=10.5483/bmbrep.2009.42.8.511;
RA   Park S.Y., Shin J.N., Woo H.N., Piya S., Moon A.R., Seo Y.W., Seol D.W.,
RA   Kim T.H.;
RT   "DOBI is cleaved by caspases during TRAIL-induced apoptotic cell death.";
RL   BMB Rep. 42:511-515(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-84, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=28981101; DOI=10.1038/cddis.2017.476;
RA   Jana S., Hsieh A.C., Gupta R.;
RT   "Reciprocal amplification of caspase-3 activity by nuclear export of a
RT   putative human RNA-modifying protein, PUS10 during TRAIL-induced
RT   apoptosis.";
RL   Cell Death Dis. 8:E3093-E3093(2017).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INTERACTION WITH DROSHA
RP   AND DGCR8, ACTIVE SITE, AND MUTAGENESIS OF ASP-344.
RX   PubMed=31819270; DOI=10.1038/s41589-019-0420-5;
RA   Song J., Zhuang Y., Zhu C., Meng H., Lu B., Xie B., Peng J., Li M., Yi C.;
RT   "Differential roles of human PUS10 in miRNA processing and tRNA
RT   pseudouridylation.";
RL   Nat. Chem. Biol. 0:0-0(2019).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, AND MUTAGENESIS OF ASP-344.
RX   PubMed=30530625; DOI=10.1261/rna.068114.118;
RA   Deogharia M., Mukhopadhyay S., Joardar A., Gupta R.;
RT   "The human ortholog of archaeal Pus10 produces pseudouridine 54 in select
RT   tRNAs where its recognition sequence contains a modified residue.";
RL   RNA 25:336-351(2019).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH ZINC.
RX   PubMed=17900615; DOI=10.1016/j.jmb.2007.08.053;
RA   McCleverty C.J., Hornsby M., Spraggon G., Kreusch A.;
RT   "Crystal structure of human Pus10, a novel pseudouridine synthase.";
RL   J. Mol. Biol. 373:1243-1254(2007).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-484.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Protein with different functions depending on its subcellular
CC       location: involved in miRNA processing in the nucleus and acts as a
CC       tRNA pseudouridylate synthase in the cytoplasm (PubMed:31819270). In
CC       the cytoplasm, acts as a pseudouridylate synthase by catalyzing
CC       synthesis of pseudouridine(54) and pseudouridine(55) from uracil-54 and
CC       uracil-55, respectively, in the psi GC loop of a subset of tRNAs
CC       (PubMed:30530625, PubMed:31819270). tRNA pseudouridylate synthase
CC       activity is enhanced by the presence of 1-methyladenosine at position
CC       53-61 of tRNAs (PubMed:30530625). In the nucleus, promotes primary
CC       microRNAs (pri-miRNAs) processing independently of its RNA
CC       pseudouridylate synthase activity (PubMed:31819270). Binds pri-miRNAs
CC       (PubMed:31819270). Modulator of TRAIL/TNFSF10-induced cell death via
CC       activation of procaspase-8 and BID cleavage (PubMed:14527409,
CC       PubMed:19712588). Required for the progression of the apoptotic signal
CC       through intrinsic mitochondrial cell death (PubMed:19712588).
CC       {ECO:0000269|PubMed:14527409, ECO:0000269|PubMed:19712588,
CC       ECO:0000269|PubMed:30530625, ECO:0000269|PubMed:31819270}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=uridine(55) in tRNA = pseudouridine(55) in tRNA;
CC         Xref=Rhea:RHEA:42532, Rhea:RHEA-COMP:10101, Rhea:RHEA-COMP:10102,
CC         ChEBI:CHEBI:65314, ChEBI:CHEBI:65315; EC=5.4.99.25;
CC         Evidence={ECO:0000269|PubMed:31819270};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42533;
CC         Evidence={ECO:0000269|PubMed:31819270};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=uridine(54) in tRNA = pseudouridine(54) in tRNA;
CC         Xref=Rhea:RHEA:57876, Rhea:RHEA-COMP:10193, Rhea:RHEA-COMP:14141,
CC         ChEBI:CHEBI:65314, ChEBI:CHEBI:65315;
CC         Evidence={ECO:0000269|PubMed:30530625, ECO:0000269|PubMed:31819270};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:57877;
CC         Evidence={ECO:0000269|PubMed:31819270};
CC   -!- SUBUNIT: Interacts with components of the microprocessor complex DROSHA
CC       and DGCR8. {ECO:0000269|PubMed:31819270}.
CC   -!- INTERACTION:
CC       Q3MIT2; Q9NX38: ABITRAM; NbExp=7; IntAct=EBI-11983583, EBI-9105722;
CC       Q3MIT2; Q04760: GLO1; NbExp=3; IntAct=EBI-11983583, EBI-1055525;
CC       Q3MIT2; P02533: KRT14; NbExp=3; IntAct=EBI-11983583, EBI-702178;
CC       Q3MIT2; P08779: KRT16; NbExp=3; IntAct=EBI-11983583, EBI-356410;
CC       Q3MIT2; Q7Z6G3-2: NECAB2; NbExp=3; IntAct=EBI-11983583, EBI-10172876;
CC       Q3MIT2; Q9UHP3: USP25; NbExp=3; IntAct=EBI-11983583, EBI-2513462;
CC       Q3MIT2; Q6GMQ7: VPS16; NbExp=3; IntAct=EBI-11983583, EBI-17974829;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28981101,
CC       ECO:0000269|PubMed:30530625, ECO:0000269|PubMed:31819270}. Cytoplasm
CC       {ECO:0000269|PubMed:31819270, ECO:0000305|PubMed:30530625}.
CC       Mitochondrion {ECO:0000269|PubMed:28981101}. Note=Localizes mainly in
CC       the nucleus (Probable) (PubMed:31819270). tRNA pseudouridylate synthase
CC       activity is restricted to the cytoplasm (PubMed:31819270). Translocates
CC       from nucleus to mitochondria during TRAIL-induced apoptosis
CC       (PubMed:28981101). {ECO:0000269|PubMed:28981101,
CC       ECO:0000269|PubMed:31819270, ECO:0000305|PubMed:30530625}.
CC   -!- PTM: Proteolytically cleaved during TRAIL-induced cell death
CC       (PubMed:19712588). Cleaved, in vitro, either by caspase-3 (CASP3) or
CC       caspase-8 (CASP8) (PubMed:19712588). {ECO:0000269|PubMed:19712588}.
CC   -!- SIMILARITY: Belongs to the pseudouridine synthase Pus10 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI46123.1; Type=Miscellaneous discrepancy; Note=Partially unspliced pre-RNA.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK056874; BAB71300.1; -; mRNA.
DR   EMBL; AL832208; CAI46123.1; ALT_SEQ; Transcribed_RNA.
DR   EMBL; CH471053; EAX00024.1; -; Genomic_DNA.
DR   EMBL; BC101680; AAI01681.1; -; mRNA.
DR   EMBL; BC101706; AAI01707.1; -; mRNA.
DR   CCDS; CCDS1865.1; -.
DR   RefSeq; NP_001309052.1; NM_001322123.1.
DR   RefSeq; NP_001309053.1; NM_001322124.1.
DR   RefSeq; NP_653310.2; NM_144709.3.
DR   RefSeq; XP_011530870.1; XM_011532568.2.
DR   RefSeq; XP_011530872.1; XM_011532570.1.
DR   RefSeq; XP_011530873.1; XM_011532571.1.
DR   RefSeq; XP_011530874.1; XM_011532572.1.
DR   RefSeq; XP_011530875.1; XM_011532573.2.
DR   RefSeq; XP_011530876.1; XM_011532574.2.
DR   RefSeq; XP_011530878.1; XM_011532576.2.
DR   PDB; 2V9K; X-ray; 2.00 A; A=1-529.
DR   PDBsum; 2V9K; -.
DR   SMR; Q3MIT2; -.
DR   BioGRID; 127335; 6.
DR   IntAct; Q3MIT2; 7.
DR   STRING; 9606.ENSP00000326003; -.
DR   iPTMnet; Q3MIT2; -.
DR   PhosphoSitePlus; Q3MIT2; -.
DR   BioMuta; PUS10; -.
DR   DMDM; 121942830; -.
DR   EPD; Q3MIT2; -.
DR   jPOST; Q3MIT2; -.
DR   MassIVE; Q3MIT2; -.
DR   MaxQB; Q3MIT2; -.
DR   PaxDb; Q3MIT2; -.
DR   PeptideAtlas; Q3MIT2; -.
DR   PRIDE; Q3MIT2; -.
DR   ProteomicsDB; 61794; -.
DR   Antibodypedia; 47429; 109 antibodies.
DR   Ensembl; ENST00000316752; ENSP00000326003; ENSG00000162927.
DR   Ensembl; ENST00000407787; ENSP00000386074; ENSG00000162927.
DR   GeneID; 150962; -.
DR   KEGG; hsa:150962; -.
DR   UCSC; uc002sao.4; human.
DR   CTD; 150962; -.
DR   DisGeNET; 150962; -.
DR   GeneCards; PUS10; -.
DR   HGNC; HGNC:26505; PUS10.
DR   HPA; ENSG00000162927; Low tissue specificity.
DR   MIM; 612787; gene.
DR   neXtProt; NX_Q3MIT2; -.
DR   OpenTargets; ENSG00000162927; -.
DR   PharmGKB; PA162400393; -.
DR   VEuPathDB; HostDB:ENSG00000162927.13; -.
DR   eggNOG; KOG2364; Eukaryota.
DR   GeneTree; ENSGT00390000007529; -.
DR   HOGENOM; CLU_028780_2_0_1; -.
DR   InParanoid; Q3MIT2; -.
DR   OMA; FALQRKF; -.
DR   OrthoDB; 1067006at2759; -.
DR   PhylomeDB; Q3MIT2; -.
DR   TreeFam; TF106109; -.
DR   PathwayCommons; Q3MIT2; -.
DR   BioGRID-ORCS; 150962; 5 hits in 995 CRISPR screens.
DR   ChiTaRS; PUS10; human.
DR   EvolutionaryTrace; Q3MIT2; -.
DR   GenomeRNAi; 150962; -.
DR   Pharos; Q3MIT2; Tbio.
DR   PRO; PR:Q3MIT2; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q3MIT2; protein.
DR   Bgee; ENSG00000162927; Expressed in liver and 171 other tissues.
DR   ExpressionAtlas; Q3MIT2; baseline and differential.
DR   Genevisible; Q3MIT2; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0070878; F:primary miRNA binding; IDA:UniProtKB.
DR   GO; GO:0009982; F:pseudouridine synthase activity; IBA:GO_Central.
DR   GO; GO:0106029; F:tRNA pseudouridine synthase activity; IDA:UniProtKB.
DR   GO; GO:0031053; P:primary miRNA processing; IDA:UniProtKB.
DR   GO; GO:0031119; P:tRNA pseudouridine synthesis; IDA:UniProtKB.
DR   InterPro; IPR020103; PsdUridine_synth_cat_dom_sf.
DR   InterPro; IPR039894; Pus10-like.
DR   PANTHER; PTHR21568; PTHR21568; 1.
DR   SUPFAM; SSF55120; SSF55120; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Coiled coil; Cytoplasm; Isomerase; Metal-binding;
KW   Mitochondrion; Nucleus; Phosphoprotein; Reference proteome;
KW   tRNA processing; Zinc.
FT   CHAIN           1..529
FT                   /note="tRNA pseudouridine synthase Pus10"
FT                   /id="PRO_0000299022"
FT   REGION          304..317
FT                   /note="RNA binding forefinger loop"
FT                   /evidence="ECO:0000255"
FT   REGION          442..457
FT                   /note="RNA binding thumb loop"
FT                   /evidence="ECO:0000255"
FT   COILED          42..89
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        344
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000269|PubMed:30530625,
FT                   ECO:0000269|PubMed:31819270"
FT   METAL           21
FT                   /note="Zinc"
FT                   /evidence="ECO:0000269|PubMed:17900615,
FT                   ECO:0007744|PDB:2V9K"
FT   METAL           24
FT                   /note="Zinc"
FT                   /evidence="ECO:0000269|PubMed:17900615,
FT                   ECO:0007744|PDB:2V9K"
FT   METAL           109
FT                   /note="Zinc"
FT                   /evidence="ECO:0000269|PubMed:17900615,
FT                   ECO:0007744|PDB:2V9K"
FT   METAL           112
FT                   /note="Zinc"
FT                   /evidence="ECO:0000269|PubMed:17900615,
FT                   ECO:0007744|PDB:2V9K"
FT   BINDING         414
FT                   /note="Substrate"
FT                   /evidence="ECO:0000255"
FT   BINDING         485
FT                   /note="Substrate"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         79
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332"
FT   MOD_RES         84
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332,
FT                   ECO:0007744|PubMed:23186163"
FT   VARIANT         484
FT                   /note="T -> I (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs1486089321)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035617"
FT   MUTAGEN         344
FT                   /note="D->A: Abolished tRNA pseudouridine synthase without
FT                   affecting ability to promote miRNA processing."
FT                   /evidence="ECO:0000269|PubMed:30530625,
FT                   ECO:0000269|PubMed:31819270"
FT   CONFLICT        208
FT                   /note="F -> L (in Ref. 1; BAB71300)"
FT                   /evidence="ECO:0000305"
FT   HELIX           6..8
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           9..18
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           22..28
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           35..38
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           41..52
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   TURN            110..117
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           118..120
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           122..134
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          142..147
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           152..169
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           176..178
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           182..198
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          207..215
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           217..220
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           221..227
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           246..255
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           258..264
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          277..285
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          288..296
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          307..315
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           318..323
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           326..330
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          333..341
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          348..362
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           370..381
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          385..395
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           398..409
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          412..422
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           426..429
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           430..434
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          437..443
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           446..448
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   TURN            449..451
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          456..470
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          473..480
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           486..491
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   TURN            493..496
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          497..499
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   HELIX           501..505
FT                   /evidence="ECO:0007744|PDB:2V9K"
FT   STRAND          509..519
FT                   /evidence="ECO:0007744|PDB:2V9K"
SQ   SEQUENCE   529 AA;  60244 MW;  44E7BD6ED9C9864E CRC64;
     MFPLTEENKH VAQLLLNTGT CPRCIFRFCG VDFHAPYKLP YKELLNELQK FLETEKDELI
     LEVMNPPPKK IRLQELEDSI DNLSQNGEGR ISVSHVGSTA SKNSNLNVCN VCLGILQEFC
     EKDFIKKVCQ KVEASGFEFT SLVFSVSFPP QLSVREHAAW LLVKQEMGKQ SLSLGRDDIV
     QLKEAYKWIT HPLFSEELGV PIDGKSLFEV SVVFAHPETV EDCHFLAAIC PDCFKPAKNK
     QSVFTRMAVM KALNKIKEED FLKQFPCPPN SPKAVCAVLE IECAHGAVFV AGRYNKYSRN
     LPQTPWIIDG ERKLESSVEE LISDHLLAVF KAESFNFSSS GREDVDVRTL GNGRPFAIEL
     VNPHRVHFTS QEIKELQQKI NNSSNKIQVR DLQLVTREAI GHMKEGEEEK TKTYSALIWT
     NKAIQKKDIE FLNDIKDLKI DQKTPLRVLH RRPLAVRARV IHFMETQYVD EHHFRLHLKT
     QAGTYIKEFV HGDFGRTKPN IGSLMNVTAD ILELDVESVD VDWPPALDD
//
